Presentation Information
[29-57-pm1-07S]FAERS-based comparison of cardiometabolic safety between long-acting cabotegravir/rilpivirine and first-line oral INSTI-based regimens
○Chihiro Nishikawa1, Shigeru Hasebe1, Yuki Miura1, Maho Kikuta1 (1. Fac. Pharm. Sci., Setsunan Univ.)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.